Involvement of urinary proteins in the rat strain difference in sensitivity to ethylene glycol-induced renal toxicity.
Ethylene glycol (EG) exposure is a common model for kidney stones, because animals accumulate calcium oxalate monohydrate (COM) in kidneys. Wistar rats are more sensitive to EG than Fischer 344 (F344) rats, with greater COM deposition in kidneys. The mechanisms by which COM accumulates differently among strains are poorly understood. Urinary proteins inhibit COM adhesion to renal cells, which could alter COM deposition in kidneys. We hypothesize that COM accumulates more in Wistar rat kidneys because of lower levels of inhibitory proteins in urine. Wistar and F344 rats were treated with 0.75% EG in drinking water for 8 wk. Twenty-four-hour urine was collected every 2 wk for analysis of urinary proteins. Similar studies were conducted for 2 wk using 2% hydroxyproline (HP) as an alternative oxalate source. Total urinary protein was higher in F344 than Wistar rats at all times. Tamm-Horsfall protein was not different between strains. Osteopontin (OPN) levels in Wistar urine and kidney tissue were higher and were further increased by EG treatment. This increase in OPN occurred before renal COM accumulation. Untreated F344 rats showed greater CD45 and ED-1 staining in kidneys than untreated Wistars; in contrast, EG treatment increased CD45 and ED-1 staining in Wistars more than in F344 rats, indicating macrophage infiltration. This increase occurred in parallel with the increase in OPN and before COM accumulation. Like EG, HP induced markedly greater oxalate concentrations in the plasma and urine of Wistar rats compared with F344 rats. These results suggest that OPN upregulation and macrophage infiltration do not completely protect against COM accumulation and may be a response to crystal retention. Because the two oxalate precursors, EG and HP, produced similar elevations of oxalate, the strain difference in COM accumulation may result more so from metabolic differences between strains than from differences in urinary proteins or inflammatory responses.
Department of Pharmacology, Toxicology, and Neuroscience, Louisiana State University Health Sciences Center, Shreveport, USA.
Yan
Y
Li
Marie C
MC
McLaren
Kenneth E
KE
McMartin
D000818:Animals; D002129:Calcium Oxalate / Q000378:metabolism; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D019855:Ethylene Glycol / Q000009:adverse effects* / Q000494:pharmacology; D006909:Hydroxyproline / Q000009:adverse effects / Q000494:pharmacology; D007668:Kidney / Q000378:metabolism; D007669:Kidney Calculi / Q000139:chemically induced* / Q000453:epidemiology*; D008297:Male; D009088:Mucoproteins / Q000652:urine*; D053495:Osteopontin / Q000652:urine*; D051381:Rats; D011916:Rats, Inbred F344; D017208:Rats, Wistar; D012307:Risk Factors; D013045:Species Specificity; D058949:Uromodulin
D009088:Mucoproteins; C548614:Umod protein, rat; D058949:Uromodulin; D053495:Osteopontin; D002129:Calcium Oxalate; D019855:Ethylene Glycol; D006909:Hydroxyproline